Trials / Completed
CompletedNCT03080701
Financial Incentives to Increase Colorectal Cancer Screening in Priority Populations
Systems of Support (SOS) to Increase Colon Cancer Screening Disparities Supplement
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 898 (actual)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The investigators propose to build on the success of the Systems of Support to Increase Colorectal Cancer trial (SOS, R01CA121125, Green) and focus on disparity groups who are less likely to be current for colorectal cancer (CRC) screening. We will test whether financial incentives increases screening uptake and decreases screening disparities. The investigators hypothesize that CRC screening rates will be higher in patients offered mailed fecal kits and financial incentives than those offered mailed fecal kits alone.
Detailed description
Study staff will send invitation letters and a questionnaire to 5,000 patients aged 50-75 not current for CRC screening, two-thirds who are identified in the electronic data as being from a non-White race, ethnicity, or who have Medicaid coverage. Those returning the survey and remaining eligible (estimated N = 1150) will be randomized to either (1) Mailed fecal kit only, or mailed fecal kit plus one of 2 types of financial incentives for completing testing: (2) a guaranteed Monetary incentive or (3) a probabilistic Lottery incentive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Auto Mailing Plus Money | Participant receives money as a thank you for completing CRC screening within 6 months. |
| BEHAVIORAL | Auto Mailing Plus Lottery | Participant has a 1 in 10 chance of winning money in a lottery for completing CRC screening within 6 months. |
Timeline
- Start date
- 2017-03-23
- Primary completion
- 2018-11-02
- Completion
- 2018-11-02
- First posted
- 2017-03-15
- Last updated
- 2019-11-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03080701. Inclusion in this directory is not an endorsement.